WVE Wave Life Sciences Ltd. - Ordinary Shares
NASDAQ · Pharmaceuticals · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Jul 30, 2026
$3,78
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$3,56rendah 52m
$20,63tinggi 52m
Kapitalisasi Pasar (MRQ)
$731M
P/E
-14.0
EPS
$-1.21
Pendapatan
$43M
lencana Anda
Rentang 52M
$4–$21
Peringkat Analis
BUY
Target Harga
$19
P/E
-14.0
ROE
·
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
WVE Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$3.78
Kapitalisasi Pasar (MRQ)
$731M
P/E
-14.0
EPS
$-1.21
Pendapatan
$43M
Rentang 52M
$4–$21
WVE Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Tentang Wave Life Sciences Ltd. - Ordinary Shares Tinjauan perusahaan dari Wikipedia
sektorHealthcare
industriPharmaceuticals
karyawan317
negaraSG
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$43M2016-12-31 → 2025-12-31
EPS$-1.212021-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | WVE | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -14.0rata-rata 5T ≈-9.2 | ≈-9.2 | · | · | |
| P/B (MRQ) | 1.6 | · | · | · | |
| Harga / FCF (TTM) | -3.8 | · | · | · | |
| Harga / Arus Kas (TTM) | -3.8 | · | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 6.2rata-rata 5T ≈9.0 | ≈9.0 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | WVE | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 10.0 | · | · | · |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | WVE | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | -60.6%rata-rata 5T ≈590.6% | ≈590.6% | · | · | |
| Revenue CAGR 3Y (CAGR Pendapatan 3T) | 127.1%rata-rata 5T ≈81.1% | ≈81.1% | · | · | |
| Revenue CAGR 5Y (CAGR Pendapatan 5T) | 16.3% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | WVE | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$134.8K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
3.3%
Laporan Berikutnya
Nov 09, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Jul 28, 2026 | $-0.34 | $-0.31 | -8.9% |
| 31 Maret 2026 | Mei 7, 2026 | $-0.13 | $-0.33 | 60.7% |
| 31 Des. 2025 | $-0.30 | $-0.27 | -10.0% | |
| 30 Sep. 2025 | $-0.32 | $-0.30 | -6.2% | |
| 30 Juni 2025 | $-0.31 | $-0.29 | -5.6% | |
| 31 Maret 2025 | $-0.29 | $-0.26 | -10.1% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $43M | $108M | $113M | $4M | $41M | $20M | $16M | $14M | $4M | $1M | $152.0K | |
| R&D Expense | $183M | $160M | $130M | $116M | $122M | $131M | $175M | $134M | $79M | $41M | $9M | |
| SG&A Expense | $75M | $59M | $51M | $51M | $46M | $43M | $49M | $40M | $27M | $16M | $10M | |
| Operating Expenses | $258M | $219M | $181M | $166M | $168M | $173M | $224M | $174M | $106M | $57M | $19M | |
| Operating Income | $-215M | $-110M | $-68M | $-163M | $-127M | $-153M | $-208M | $-160M | $-102M | $-56M | $-19M | |
| Other Non-op | $527.0K | $3M | $2M | $7.0K | $5M | $2M | $10M | $10M | $-331.0K | $-50.0K | $56.0K | |
| Pretax Income | $-204M | $-97M | $-58M | $-161M | $-122M | $-151M | $-194M | $-147M | $-101M | $-55M | $-19M | |
| Income Tax | $0 | $0 | $-677.0K | $681.0K | $-204.0K | $-841.0K | $0 | $69.0K | $842.0K | $482.0K | $44.0K | |
| Net Income | $-204M | $-97M | $-58M | $-162M | $-122M | $-150M | $-194M | $-147M | $-102M | $-56M | $-19M | |
| EPS (Basic) | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 | · | · | · | · | · | · | |
| Shares (Basic) | 168,649,795 | 138,277,468 | 106,097,268 | 78,855,810 | 51,825,566 | · | · | · | · | · | · | |
| Shares (Diluted) | 168,649,795 | 138,277,468 | 106,097,268 | 78,855,810 | 51,825,566 | · | · | · | · | · | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $602M | $302M | $200M | $88M | $151M | $184M | $147M | $175M | $143M | $150M | $161M | |
| Receivables | $1M | $1M | $21M | · | · | $30M | $20M | $10M | $1M | · | · | |
| Prepaid Expense | $8M | $10M | $10M | $8M | $7M | $10M | $10M | $7M | $7M | $1M | $146.0K | |
| Other Current Assets | $3M | $7M | $4M | $2M | $5M | $5M | $9M | $11M | · | · | · | |
| Current Assets | $615M | $320M | $235M | $99M | $163M | $230M | $185M | $202M | $150M | $152M | $161M | |
| PP&E (Net) | $7M | $10M | $13M | $17M | $22M | $29M | $36M | $40M | $27M | $9M | $3M | |
| PP&E (Gross) | $57M | $56M | $56M | $55M | $54M | $54M | $53M | $49M | $32M | $11M | $4M | |
| Accum. Depreciation | $50M | $46M | $43M | $38M | $32M | $25M | $17M | $10M | $4M | $2M | $2M | |
| Other Non-current Assets | $16.0K | $55.0K | $156.0K | · | · | · | · | · | · | · | · | |
| Total Assets | $638M | $352M | $275M | $146M | $207M | $279M | $284M | $296M | $182M | $165M | $165M | |
| Accounts Payable | $16M | $16M | $13M | $17M | $7M | $14M | $9M | $13M | $8M | $5M | $3M | |
| Accrued Liabilities | $7M | $5M | $2M | $4M | $4M | $2M | $5M | $6M | $3M | · | · | |
| Current Liabilities | $95M | $111M | $186M | $72M | $64M | $121M | $118M | $130M | $18M | $12M | $4M | |
| Capital Leases | $9M | $18M | $25M | $32M | $25M | $26M | $29M | · | · | $16.0K | $78.0K | |
| Other Non-current Liabilities | · | · | · | $190.0K | · | $474.0K | $2M | $2M | $2M | $796.0K | $163.0K | |
| Total Liabilities | $112M | $135M | $227M | $184M | $167M | $189M | $213M | $215M | $34M | $22M | $4M | |
| Common Stock | $1.62B | $1.18B | $935M | $803M | $750M | $694M | $540M | $375M | $310M | $216M | $185M | |
| Paid-in Capital | $228M | $156M | $129M | $119M | $88M | $72M | $57M | $38M | $22M | $10M | $3M | |
| Retained Earnings | $-1.33B | $-1.12B | $-1.02B | $-967M | $-806M | $-683M | $-533M | $-340M | $-193M | $-90M | $-35M | |
| AOCI | $-250.0K | $-262.0K | $-124.0K | $-29.0K | $181.0K | $389.0K | $267.0K | $153.0K | $116.0K | $-291.0K | $41.0K | |
| Stockholders' Equity | $518M | $210M | $40M | $-45M | $32M | $83M | $64M | $73M | $140M | $135M | $153M | |
| Liabilities + Equity | $638M | $352M | $275M | $146M | $207M | $279M | $284M | $296M | $182M | $165M | $165M | |
| Shares Outstanding | 187,660,263 | 153,037,286 | 119,162,234 | 86,924,643 | 59,841,116 | 48,778,678 | 34,340,690 | 29,472,197 | 27,829,079 | 23,502,169 | 21,551,423 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | $2M | $784.0K | $594.0K | |
| Stock-based Comp | · | · | · | · | · | · | · | · | · | · | $4M | |
| Deferred Tax | $0 | $0 | $0 | · | · | · | · | · | $908.0K | $-698.0K | $36.0K | |
| Operating Cash Flow | $-187M | $-151M | $-19M | $-128M | $-89M | $-116M | $-188M | $-23M | $-84M | $-32M | $-13M | |
| CapEx | $718.0K | $938.0K | $1M | $1M | $560.0K | $1M | $4M | $10M | $19M | $6M | $2M | |
| Investing Cash Flow | $-718.0K | $-938.0K | $-1M | $-1M | $-560.0K | $-1M | $-4M | $-10M | $-19M | $-6M | · | |
| Stock Issued | · | · | $94M | $51M | · | $94M | $162M | $60M | $94M | $30M | $12M | |
| Financing Cash Flow | $488M | $254M | $133M | $67M | $56M | $155M | $164M | $65M | $94M | $29M | · | |
| Net Change in Cash | $300M | $102M | $112M | $-62M | $-34M | $37M | $-28M | $32M | $-8M | $-8M | $160M | |
| Taxes Paid | · | · | · | · | · | · | · | · | $-11.0K | $554.0K | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS (TTM) | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 | · | · | · | · | · | · |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -60.6% | -4.4% | 3005.1% | -91.1% | 104.0% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 127.1% | 38.3% | 78.0% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 16.3% | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $43M | $108M | $113M | $4M | $41M | $20M | $16M | $14M | $4M | $1M | $152.0K | |
| Net Income TTM | $-204M | $-97M | $-58M | $-162M | $-122M | $-150M | $-194M | $-147M | $-102M | $-56M | $-19M | |
| P/E | -14.0 | -17.7 | -9.4 | -3.4 | -1.3 | · | · | · | · | · | · | |
| P / Tangible Book | 6.2 | 9.0 | 15.2 | · | 5.8 | 4.6 | · | · | · | · | · | |
| Earnings Yield | -7.1% | -5.7% | -10.7% | -29.3% | -75.2% | · | · | · | · | · | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $38M | · | · | $9M | $9M | · | · | $20M | $13M | $49M | $22M | $13M | $285.0K | $375.0K | $2M | |
| R&D Expense | $51M | $47M | $53M | $46M | $43M | $41M | $45M | $41M | $40M | $33M | $32M | $33M | $31M | $28M | $30M | $27M | |
| SG&A Expense | $25M | $22M | $21M | $18M | $18M | $18M | $16M | $15M | $14M | $14M | $13M | $12M | $12M | $12M | $13M | $12M | |
| Operating Expenses | $76M | $70M | $74M | $64M | $61M | $59M | $61M | $56M | $55M | $47M | $45M | $46M | $43M | $39M | $43M | $40M | |
| Operating Income | $-74M | $-31M | $-56M | $-56M | $-53M | $-50M | $23M | $-64M | $-35M | $-34M | $4M | $-23M | $-30M | $-39M | $-42M | $-38M | |
| Interest Income | $5M | $5M | · | $2M | $2M | $3M | · | $2M | $2M | $3M | · | · | · | · | · | · | |
| Other Non-op | $-275.0K | $-80.0K | $234.0K | $324.0K | $-82.0K | $51.0K | $3M | $337.0K | $-18.0K | $365.0K | $171.0K | $118.0K | $1M | $-701.0K | $744.0K | $254.0K | |
| Pretax Income | $-69M | $-26M | $-53M | $-54M | $-50M | $-47M | $29M | $-62M | $-33M | $-32M | $7M | $-21M | $-27M | $-39M | $-41M | $-38M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-677.0K | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-69M | $-26M | $-53M | $-54M | $-50M | $-47M | $29M | $-62M | $-33M | $-32M | $7M | $-21M | $-27M | $-39M | $-41M | $-38M | |
| EPS (Basic) | $-0.34 | $-0.13 | $-0.29 | $-0.32 | $-0.31 | $-0.29 | $0.26 | $-0.47 | $-0.25 | $-0.24 | $0.07 | $-0.20 | $-0.27 | $-0.42 | $-0.62 | $-0.62 | |
| EPS (Diluted) | $-0.34 | $-0.13 | $-0.29 | $-0.32 | $-0.31 | $-0.29 | $0.26 | $-0.47 | $-0.25 | $-0.24 | $0.07 | $-0.20 | $-0.27 | $-0.42 | $-0.62 | $-0.62 | |
| Shares (Basic) | 204,008,712 | 200,167,869 | · | 167,739,208 | 163,987,640 | 162,572,026 | · | 132,563,467 | 129,527,003 | 129,271,678 | 106,025,063 | 105,462,414 | 102,056,712 | 93,900,484 | 66,479,293 | 60,516,616 | |
| Shares (Diluted) | 204,008,712 | 200,167,869 | · | 167,739,208 | 163,987,640 | 162,572,026 | · | 132,563,467 | 129,527,003 | 129,271,678 | 106,975,231 | 105,462,414 | 102,056,712 | 93,900,484 | 66,479,293 | 60,516,616 | |
| EBITDA | · | $-31M | · | $-56M | $-53M | $-50M | · | $-64M | $-35M | · | $4M | $-23M | $-30M | $-39M | $-42M | $-38M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $368M | $545M | $602M | $196M | $208M | $243M | $302M | $311M | $154M | $181M | $140M | $173M | $208M | $97M | $123M | $62M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | $25M | $25M | $50M | |
| Receivables | $888.0K | $0 | $1M | $10M | $2M | · | $1M | $0 | $1M | $0 | $7M | · | · | · | · | · | |
| Prepaid Expense | $12M | $13M | $8M | $7M | $7M | $8M | $10M | $11M | $12M | $11M | $8M | $9M | $9M | $7M | $5M | $7M | |
| Other Current Assets | $4M | $3M | $3M | $3M | $7M | $7M | $7M | $3M | $5M | $5M | $4M | $3M | $3M | $2M | $7M | $6M | |
| Current Assets | $508M | $561M | $615M | $215M | $224M | $258M | $320M | $325M | $172M | $197M | $159M | $185M | $220M | $131M | $160M | $124M | |
| PP&E (Net) | $7M | $7M | $7M | $8M | $9M | $10M | $10M | $11M | $12M | $12M | $14M | $15M | $16M | $19M | $20M | $21M | |
| PP&E (Gross) | · | · | $57M | · | · | · | $56M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $51M | $50M | $50M | $49M | $48M | $47M | $46M | $45M | $44M | $44M | $42M | $40M | $39M | · | · | · | |
| Other Non-current Assets | $667.0K | $386.0K | $16.0K | $22.0K | $728.0K | $448.0K | $55.0K | · | · | · | · | · | · | · | · | · | |
| Total Assets | $558M | $584M | $638M | $241M | $252M | $288M | $352M | $359M | $209M | $235M | $200M | $230M | $267M | $182M | $213M | $167M | |
| Accounts Payable | $20M | $19M | $16M | $14M | $15M | $14M | $16M | $13M | $18M | $12M | $13M | $12M | $12M | $16M | $11M | $10M | |
| Accrued Liabilities | $5M | $5M | $7M | $5M | $3M | $2M | $5M | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $3M | $3M | |
| Current Liabilities | $51M | $50M | $95M | $86M | $87M | $87M | $111M | $171M | $173M | $166M | $100M | $140M | $133M | $64M | $64M | $58M | |
| Capital Leases | $40M | $7M | $9M | $11M | $14M | $16M | $18M | $20M | $22M | $24M | $27M | $29M | $31M | $34M | $35M | $24M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $190.0K | $190.0K | · | · | $868.0K | |
| Total Liabilities | $105M | $72M | $112M | $109M | $105M | $109M | $135M | $209M | $204M | $202M | $233M | $274M | $294M | $178M | $174M | $160M | |
| Common Stock | $1.63B | $1.63B | $1.62B | $1.22B | $1.19B | $1.18B | $1.18B | $1.14B | $951M | $950M | $841M | $840M | $838M | $803M | $802M | $751M | |
| Paid-in Capital | $248M | $237M | $228M | $174M | $168M | $161M | $156M | $153M | $136M | $132M | $127M | $125M | $122M | $117M | $113M | $92M | |
| Retained Earnings | $-1.42B | $-1.35B | $-1.33B | $-1.27B | $-1.22B | $-1.17B | $-1.12B | $-1.15B | $-1.09B | $-1.06B | $-1.01B | $-1.02B | $-995M | $-924M | $-885M | $-843M | |
| AOCI | $-172.0K | $-254.0K | $-250.0K | $-190.0K | $-161.0K | $-204.0K | $-262.0K | $-159.0K | $-279.0K | $-198.0K | $-182.0K | $-150.0K | $-50.0K | $-123.0K | $-47.0K | $95.0K | |
| Stockholders' Equity | $454M | $512M | $518M | $125M | $139M | $172M | $210M | $142M | $-3M | $25M | $-40M | $-52M | $-35M | $-5M | $31M | $-53.0K | |
| Liabilities + Equity | $558M | $584M | $638M | $241M | $252M | $288M | $352M | $359M | $209M | $235M | $200M | $230M | $267M | $182M | $213M | $167M | |
| Shares Outstanding | 193,277,622 | 192,337,566 | 187,660,263 | 160,288,481 | 155,673,292 | 154,093,313 | 153,037,286 | 148,392,939 | 122,479,289 | 122,321,384 | 99,011,901 | 98,566,816 | 98,104,844 | 86,841,523 | 86,724,658 | 60,859,968 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-54M | $-60M | $-34M | $-45M | $-46M | $-63M | $-44M | $-46M | $-27M | $-33M | $-34M | $-37M | $86M | $-26M | $-29M | $-40M | |
| CapEx | $884.0K | $438.0K | $-1.0K | $248.0K | $306.0K | $165.0K | $86.0K | $383.0K | $52.0K | $417.0K | $198.0K | $72.0K | $489.0K | $457.0K | $492.0K | $208.0K | |
| Investing Cash Flow | $-123M | $-438.0K | $1.0K | $-248.0K | $-306.0K | $-165.0K | $-86.0K | $-383.0K | $-52.0K | $-417.0K | $-198.0K | $-72.0K | $-489.0K | $-501.0K | $25M | $-50M | |
| Stock Issued | · | · | · | · | · | · | · | $174M | $0 | $14M | $-35M | $-35M | $0 | $-229.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | $35M | · | · | · | |
| Financing Cash Flow | $330.0K | $3M | $440M | $33M | $12M | $4M | $35M | $204M | $653.0K | $15M | $2M | $2M | $35M | $17.0K | $66M | $1M | |
| Net Change in Cash | $-177M | $-57M | $406M | $-12M | $-35M | $-59M | $-9M | $157M | $-27M | $-19M | $-33M | $-36M | $120M | $-26M | $61M | $-89M | |
| Free Cash Flow | · | $-60M | · | · | · | $-63M | · | · | · | · | · | · | $85M | · | · | $-40M |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -81.8% | · | · | -606.5% | -542.8% | · | · | -177.7% | · | 9.0% | -106.2% | -234.2% | -13648.8% | -11243.7% | -2176.8% | |
| Net Margin | · | -68.2% | · | · | -580.2% | -510.9% | · | · | -167.2% | · | 14.7% | -95.5% | -212.0% | -13685.6% | -11012.3% | -2160.8% | |
| Pretax Margin | · | -68.2% | · | · | -580.2% | -510.9% | · | · | -167.2% | · | 13.4% | -95.5% | -212.0% | -13685.6% | -11012.3% | -2160.8% | |
| EBITDA Margin | · | -81.8% | · | · | -606.5% | -542.8% | · | · | -177.7% | · | 9.0% | -106.2% | -234.2% | -13648.8% | -11243.7% | -2176.8% | |
| ROA | · | -6.0% | · | -17.9% | -21.9% | -17.9% | · | -22.1% | -15.0% | · | 3.8% | -9.5% | -12.6% | -20.4% | -19.7% | -18.4% | |
| ROE | · | -7.6% | · | -40.5% | -74.3% | -47.5% | · | -122.2% | 119.3% | · | -32.2% | 203.2% | 157.7% | -307.3% | -156.5% | -143.3% | |
| ROIC | · | -6.1% | · | -45.2% | -37.9% | -29.0% | · | -45.1% | 1006.5% | · | -12.1% | 45.4% | 87.2% | 860.8% | -136.2% | 71875.5% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 11.3 | · | 2.5 | 2.6 | 3.0 | · | 1.9 | 1.0 | · | 1.6 | 1.3 | 1.7 | 2.0 | 2.5 | 2.1 | |
| Quick Ratio | · | 10.9 | · | 2.4 | 2.4 | 2.8 | · | 1.8 | 0.9 | · | 1.5 | 1.2 | 1.6 | 1.9 | 2.3 | 1.9 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.1 | · | · | 0.0 | 0.0 | · | · | 0.1 | · | 0.3 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | 6.0 | · | · | · | 30.5 | · | 3.3 | · | · | · | · | · |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $2.66 | · | $0.78 | $0.89 | $1.11 | · | $0.95 | $-0.03 | · | $-0.41 | $-0.52 | $-0.35 | $-0.05 | $0.36 | $-0.00 | |
| Revenue / Share | · | $0.19 | · | · | $0.05 | $0.06 | · | · | $0.15 | · | $0.46 | $0.21 | $0.13 | $0.00 | $0.01 | · | |
| Cash Flow / Share | · | $-0.30 | · | · | · | $-0.39 | · | · | · | · | · | · | $0.84 | · | · | · | |
| Cash / Share | · | $2.83 | · | $1.22 | $1.34 | $1.58 | · | $2.10 | $1.26 | · | $1.41 | $1.75 | $2.12 | $1.12 | $1.42 | $1.01 | |
| EPS (TTM) | $-1.08 | $-1.05 | · | $-0.66 | $-0.81 | $-0.75 | · | $-1.10 | $-0.56 | $-0.51 | $-0.79 | $-1.28 | $-1.70 | $-2.27 | $-1.97 | $-2.13 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | $110M | $110M | $113M | $85M | $37M | $15M | $4M | $40M | $43M | |
| Net Income TTM | $-202M | $-184M | · | $-122M | $-130M | $-112M | · | $-143M | $-73M | $-62M | $-85M | $-131M | $-151M | $-153M | $-120M | $-118M | |
| Market Cap | · | $1.39B | · | $1.17B | $1.01B | $1.25B | · | $1.22B | $611M | · | $569M | $359M | $425M | $313M | $282M | $122M | |
| P/E | -5.4 | -6.9 | · | -11.1 | -8.0 | -10.8 | · | -7.5 | -8.9 | -12.1 | -7.3 | -2.8 | -2.5 | -1.6 | -1.6 | -0.9 | |
| P/S | · | · | · | · | · | · | · | 11.0 | 5.5 | · | 6.7 | 9.8 | 28.6 | 75.1 | 7.0 | 2.8 | |
| P/B | · | 2.7 | · | 9.4 | 7.3 | 7.2 | · | 8.6 | -175.8 | · | -14.1 | -6.9 | -12.2 | -69.4 | 9.1 | -2296.6 | |
| P / Tangible Book | 2.5 | 2.7 | · | 9.4 | 7.3 | 7.2 | · | 8.6 | · | 29.7 | · | · | · | · | 9.1 | · | |
| P / Cash Flow | · | -23.4 | · | · | · | -19.8 | · | · | · | · | · | · | 5.0 | · | · | -3.1 | |
| Earnings Yield | -18.6% | -14.5% | · | -9.0% | -12.5% | -9.3% | · | -13.4% | -11.2% | -8.3% | -13.7% | -35.2% | -39.3% | -62.9% | -60.6% | -106.5% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $43M | $108M | $113M | $4M | $41M |
| Laba Bersih | $-204M | $-97M | $-58M | $-162M | $-122M |
| EPS Dilusian | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 |
Tidak ada data untuk laporan ini
Data fundamental belum cukup untuk membuat laporan ini.
Tidak ada data untuk laporan ini
Data fundamental belum cukup untuk membuat laporan ini.
Pemilik institusional (13F) 260 pengaju · $1.1B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
260
Nilai yang dipegang
$1.1B
Posisi baru
50
Posisi yang keluar
39
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 50 (-7 vs Kuartal sebelumnya) | 39 (+3 vs Kuartal sebelumnya) | 99 (-14 vs Kuartal sebelumnya) | 59 (+5 vs Kuartal sebelumnya) | +5.4M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $156.727.684 | 26.975.505 | 14,03% | Saham |
| BlackRock, Inc. | $111.566.297 | 19.202.461 | 9,99% | Saham |
| GSK plc | $106.007.465 | 18.245.691 | 9,49% | Saham |
| VANGUARD GROUP INC | $60.753.682 | 3.573.746 | 5,44% | Saham |
| MAVERICK CAPITAL LTD | $59.715.848 | 10.278.115 | 5,35% | Saham |
| Driehaus Capital Management LLC | $31.624.661 | 5.443.143 | 2,83% | Saham |
| PRIMECAP MANAGEMENT CO/CA/ | $31.110.354 | 5.354.622 | 2,79% | Saham |
| 683 Capital Management, LLC | $28.759.500 | 4.950.000 | 2,57% | Saham |
| FMR LLC | $28.599.589 | 4.922.477 | 2,56% | Saham |
| STATE STREET CORP | $28.116.432 | 4.839.317 | 2,52% | Saham |
| READYSTATE ASSET MANAGEMENT LP | $27.464.678 | 4.727.139 | 2,46% | Saham |
| M28 Capital Management LP | $26.657.930 | 4.588.284 | 2,39% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $22.489.218 | 3.869.998 | 2,01% | Saham |
| TWO SIGMA INVESTMENTS, LP | $21.541.656 | 3.707.686 | 1,93% | Saham |
| ALGERT GLOBAL LLC | $16.370.343 | 2.817.615 | 1,47% | Saham |
| Qube Research & Technologies Ltd | $16.128.560 | 2.776.000 | 1,44% | Saham |
| Squarepoint Ops LLC | $14.765.778 | 2.541.442 | 1,32% | Saham |
| MORGAN STANLEY | $14.075.916 | 2.422.705 | 1,26% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12.263.463 | 2.110.751 | 1,10% | Saham |
| Pfizer Inc | $10.931.250 | 1.875.000 | 0,98% | Saham |
| MILLENNIUM MANAGEMENT LLC | $10.523.548 | 1.811.282 | 0,94% | Saham |
| D. E. Shaw & Co., Inc. | $10.296.645 | 1.772.228 | 0,92% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $10.175.651 | 1.751.403 | 0,91% | Saham |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $9.920.932 | 1.746.643 | 0,89% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $9.920.137 | 1.707.809 | 0,89% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $9.903.261 | 1.704.520 | 0,89% | Saham |
| AQR CAPITAL MANAGEMENT LLC | $9.575.141 | 1.648.045 | 0,86% | Saham |
| GOLDMAN SACHS GROUP INC | $9.425.807 | 1.622.342 | 0,84% | Saham |
| Point72 Asset Management, L.P. | $8.627.786 | 1.484.989 | 0,77% | Saham |
| FEDERATED HERMES, INC. | $8.518.820 | 1.466.234 | 0,76% | Saham |
| RTW INVESTMENTS, LP | $7.843.500 | 1.350.000 | 0,70% | Saham |
| NORTHERN TRUST CORP | $7.282.835 | 1.253.500 | 0,65% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7.114.025 | 1.224.445 | 0,64% | Saham |
| EMERALD ADVISERS, LLC | $7.111.237 | 1.223.965 | 0,64% | Saham |
| MARSHALL WACE, LLP | $5.807.286 | 999.533 | 0,52% | Saham |
| SymBiosis Capital Partners, LLC | $5.437.500 | 750.000 | 0,49% | Saham |
| Pictet Asset Management Holding SA | $5.330.146 | 917.409 | 0,48% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $5.157.403 | 887.677 | 0,46% | Saham |
| Aberdeen Group plc | $5.092.221 | 876.458 | 0,46% | Saham |
| EMERALD MUTUAL FUND ADVISERS TRUST | $4.926.874 | 847.999 | 0,44% | Saham |
| BAKER BROS. ADVISORS LP | $4.779.527 | 822.638 | 0,43% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $4.712.241 | 811.057 | 0,42% | Saham |
| CAPITAL FUND MANAGEMENT S.A. | $4.268.874 | 734.746 | 0,38% | Saham |
| SPHERA FUNDS MANAGEMENT LTD. | $3.708.360 | 638.272 | 0,33% | Saham |
| JPMORGAN CHASE & CO | $3.546.519 | 618.172 | 0,32% | Saham |
| Y-Intercept (Hong Kong) Ltd | $3.544.646 | 610.094 | 0,32% | Saham |
| Susquehanna Portfolio Strategies, LLC | $3.533.607 | 608.194 | 0,32% | Saham |
| TANG CAPITAL MANAGEMENT LLC | $3.486.000 | 600.000 | 0,31% | Saham |
| Walleye Capital LLC | $3.401.482 | 585.453 | 0,30% | Saham |
| Nuveen, LLC | $3.191.328 | 549.282 | 0,29% | Saham |
Aktivis & pemilik 5%+ 4 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×9 pengajuan | 11 Agu 2026 | 16,80% | Amandemen | · | SEC |
| Shin Nippon Biomedical Laboratories, Ltd., SNBL USA, Ltd., Ken Takanashi ×6 pengajuan | 12 Agu 2022 | · | Pengajuan awal | · | SEC |
| Kagoshima Shinsangyo Sousei Investment Limited Partnership, Kagoshima Development Co. Ltd. ×5 pengajuan | 20 Juli 2022 | · | Pengajuan awal | · | SEC |
| RA Capital Management, LLC, Peter Kolchinsky ×3 pengajuan | 28 Jan. 2019 | · | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 22 orang dalam · 8 pejabat · 9 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Paul Bolno | President and CEO | 5 Feb. 2026 A | 275.520 | 0 | 1 | $-140.956 |
| Kyle Moran | Chief Financial Officer | 5 Feb. 2026 A | 134.385 | 0 | 7 | $-4.151.988 |
| David G Gaiero | Interim CFO | 3 Maret 2020 A | 6.392 | 0 | 0 | $0 |
| Keith Regnante | Chief Financial Officer | 7 Maret 2019 A | 29.186 | 0 | 0 | $0 |
| Chris Francis | SVP, Corporate Development, Head of Emerging Areas | 26 Feb. 2026 M | 61.867 | 0 | 14 | $-7.103.233 |
| Chandra Vargeese | Chief Technology Officer, Head of Platform Discovery Sciences | 5 Feb. 2026 A | 408.246 | 0 | 1 | $-43.417 |
| Michael A. Panzara | Chief Medical Officer, Head of Therapeutics Discovery and Development | 25 Juli 2022 A | 109.103 | 0 | 0 | $0 |
| Mark Baldry | Chief Commerical Officer | 5 Agu 2019 A | 39.000 | 0 | 0 | $0 |
| Gregory L. Verdine | Direktur | 8 Des. 2025 S | 275.217 | 0 | 2 | $-269.461 |
| Christian O Henry | Direktur | 8 Des. 2025 M | 12.700 | 0 | 4 | $-1.369.324 |
| Mark Corrigan | Direktur | 8 Des. 2025 S | 28.815 | 0 | 2 | $-217.265 |
| Amy Pott | Direktur | 18 Agu 2020 A | · | 0 | 0 | $0 |
| Peter Kolchinsky | Direktur | 18 Agu 2020 A | · | 0 | 0 | $0 |
| Koji Miura | Direktur | 15 Agu 2019 A | · | 0 | 0 | $0 |
| Masaharu Tanaka | Direktur | 10 Nov. 2016 A | · | 0 | 0 | $0 |
| Takeshi Wada | Direktur | 10 Nov. 2016 A | · | 0 | 0 | $0 |
| GSK plc | Pemilik 10% | 11 Des. 2025 P | 18.245.691 | 1 | 0 | $27.930.000 |
| Adrian Rawcliffe | · | 12 Agu 2026 S | 0 | 0 | 3 | $-806.604 |
| Tan Aik Na | · | 11 Agu 2026 S | 24.968 | 0 | 9 | $-1.825.754 |
| Ken Takanashi | · | 11 Agu 2026 S | 20.079 | 0 | 1 | $-23.223 |
| Heidi L Wagner | · | 11 Agu 2026 M | 44.930 | 0 | 3 | $-231.070 |
| Roberto Guerciolini | · | 7 Des. 2016 M | 4.000 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 30 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1,11% | 41.500 NS | 31 Juli 2026 | N-PORT |
| IHE · iShares Trust | 0,16% | 562.937 SH | 11 Sep. 2026 | Harian |
| IWC · iShares Trust | 0,15% | 470.896 SH | 11 Sep. 2026 | Harian |
| IBB · iShares Trust | 0,06% | 1.217.594 SH | 11 Sep. 2026 | Harian |
| NUSC · Nushares ETF Trust | 0,05% | 122.389 NS | 31 Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,05% | 13.788 SH | 2 Okt. 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,05% | 111.824 SH | 19 Agu 2026 | Harian |
| RSSL · Global X Funds | 0,02% | 66.050 NS | 31 Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,02% | 3.532.850 SH | 11 Sep. 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 793.588 SH | 19 Agu 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,01% | 386.104 NS | 31 Juli 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 86.919 SH | 2 Okt. 2026 | Harian |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1.751.403 SH | 19 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,01% | 390.910 SH | 19 Agu 2026 | Harian |
| ISCG · iShares Trust | 0,01% | 14.841 SH | 11 Sep. 2026 | Harian |
| WSML · iShares Trust | 0,01% | 7.302 SH | 11 Sep. 2026 | Harian |
| DXUV · Dimensional ETF Trust | 0,00% | 4.263 NS | 31 Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 19.243 NS | 31 Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 88.152 SH | 11 Sep. 2026 | Harian |
| DFAC · Dimensional ETF Trust | 0,00% | 195.202 NS | 31 Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 64.397 SH | 10 Sep. 2026 | Harian |
| DFSU · Dimensional ETF Trust | 0,00% | 6.250 NS | 31 Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 248.363 SH | 11 Sep. 2026 | Harian |
| DFAU · Dimensional ETF Trust | 0,00% | 19.385 NS | 31 Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 33.180 NS | 31 Juli 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 10.069 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 11.431 SH | 19 Agu 2026 | Harian |
| IWN · iShares Trust | · | 1.201.565 SH | 11 Sep. 2026 | Harian |
| ISCB · iShares Trust | · | 6.085 SH | 11 Sep. 2026 | Harian |
| ISCV · iShares Trust | · | 18.901 SH | 11 Sep. 2026 | Harian |
WVE Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 21 analis
BELI
Target median
$15.00
+296,8%
7 33,3%
Beli Kuat
13 61,9%
Beli
1 4,8%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
17 analis · 2026-09-28Target rata-rata $18.53 +390,2%
← Di bawah semua target
Harga saat ini $3.78
Rendah$10.00
Rata-rata$18.53
Tinggi$42.00
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Jul 30, 2026